{
    "nct_id": "NCT04432727",
    "official_title": "A Feasibility Study Evaluating the Impact Flexitouch Plus With Connectivity Has on Compliance in Patients With Breast Cancer-Related Lymphedema (BCRL)",
    "inclusion_criteria": "1. Female 18 years of age or older\n2. Diagnosis of unilateral breast cancer-related lymphedema\n3. Willing and able to give informed consent (remotely or in person)\n4. Willing and able to comply with the study protocol requirements and all study-related visit requirements, including the ability to participate remotely\n5. Willing and able to receive text messages from sponsor\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. In-home use of PCD within previous 3 months\n2. Phase-one CDT within previous 1 month or planned phase-one CDT during study participation Phase-one CDT defined as professionally administered MLD and/or multi-layer short stretch compressive bandaging.\n3. Inability to be fit for PCD garments\n4. Heart failure (acute pulmonary edema, decompensated acute heart failure)\n5. Acute venous disease (acute thrombophlebitis, acute deep venous thrombosis, acute pulmonary embolism)\n6. Active skin or limb infection/inflammatory disease (acute cellulitis, other uncontrolled skin or untreated inflammatory skin disease) on the arms or trunk\n7. Currently receiving treatment for cancer with curative intent.\n8. Any circumstance where increased lymphatic or venous return is undesirable\n9. Currently pregnant or trying to become pregnant\n10. Known inability to receive cell phone connection where FT-CC therapy will be administered",
    "miscellaneous_criteria": ""
}